GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genxone SA (WAR:GX1) » Definitions » Other Long Term Assets

Genxone (WAR:GX1) Other Long Term Assets : zł0.06 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Genxone Other Long Term Assets?

Genxone's other long-term assets for the quarter that ended in Dec. 2024 was zł0.06 Mil.

Genxone's quarterly other long-term assets increased from Jun. 2024 (zł1.25 Mil) to Sep. 2024 (zł1.31 Mil) but then stayed the same from Sep. 2024 (zł1.31 Mil) to Dec. 2024 (zł0.06 Mil).

Genxone's annual other long-term assets declined from Dec. 2022 (zł2.54 Mil) to Dec. 2023 (zł1.09 Mil) and declined from Dec. 2023 (zł1.09 Mil) to Dec. 2024 (zł0.06 Mil).

Genxone Other Long Term Assets Historical Data

The historical data trend for Genxone's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genxone Other Long Term Assets Chart

Genxone Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
Get a 7-Day Free Trial 2.79 1.78 2.54 1.09 0.06

Genxone Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.09 1.18 1.25 1.31 0.06

Genxone Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Genxone Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genxone SA (WAR:GX1) » Definitions » Other Long Term Assets
Comparable Companies
WAR:RNT WAR:SCS WAR:PUR WAR:PHR WAR:RDG WAR:NNG VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270 SMMT RPRX XKRX:196170 OCSE:GMAB
Traded in Other Exchanges
N/A
Address
ul. Kobaltowa 6, Zlotniki, Suchy Las, POL, 62-002
Website
https://www.genxone.eu
Genxone SA is a biotechnology company that applies nanopore sequencing technology (third-generation of NGS) to many areas of science and business, including genetic diagnostics and the food industry. It specializes in developing new products and solutions based on the latest technologies of nucleic acid sequencing. The company's services include NANOPORE SEQUENCING that includes Whole Genome Sequencing, Bespoke Analysis, Metagenome Sequencing, Bioinformatic Analysis, 16S and/or ITS Gene Sequencing, and RNA Sequencing; and DIAGNOSTIC TESTS that includes Gastrointestinal Infections Panel, Respiratory Infections Panel, Urogenital Infection Panel, and Nervous System Infection Panel.

Genxone Headlines

No Headlines